136 related articles for article (PubMed ID: 11149124)
1. Interferon treatment on glomerulonephritis associated with hepatitis C virus.
Matsumoto S; Nakajima S; Nakamura K; Etani Y; Hirai H; Shimizu N; Yokoyama H; Kobayashi Y; Tajiri H; Shima M; Okada S
Pediatr Nephrol; 2000 Dec; 15(3-4):271-3. PubMed ID: 11149124
[TBL] [Abstract][Full Text] [Related]
2. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
Ahmed MS; Wong CF; Shawki H; Kapoor N; Pandya BK
Clin Nephrol; 2008 Apr; 69(4):298-301. PubMed ID: 18397706
[TBL] [Abstract][Full Text] [Related]
3. Effects of pegylated interferon alpha-2a on hepatitis-C-virus-associated glomerulonephritis.
Sugiura T; Yamada T; Kimpara Y; Fujita N; Goto K; Koyama N
Pediatr Nephrol; 2009 Jan; 24(1):199-202. PubMed ID: 18696119
[TBL] [Abstract][Full Text] [Related]
4. Role of ribavirin in membranoproliferative glomerulonephritis associated with hepatitis C virus infection refractory to alpha-interferon.
Pérez-Calvo J; Lasierra P; Moros M; Iñigo P
Nephron; 2002 Oct; 92(2):459-62. PubMed ID: 12218331
[TBL] [Abstract][Full Text] [Related]
5. Effect of human leukocyte alpha interferon on cryoglobulinaemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection.
Gilli P; Stabellini N; Storari A; Gualandi G; Guerra G; Ghinelli F
Nephrol Dial Transplant; 1996 Mar; 11(3):526-8. PubMed ID: 8671825
[No Abstract] [Full Text] [Related]
6. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon-alpha.
Yamabe H; Johnson RJ; Gretch DR; Osawa H; Inuma H; Sasaki T; Kaizuka M; Tamura N; Tsunoda S; Fujita Y
Am J Kidney Dis; 1995 Jan; 25(1):67-9. PubMed ID: 7810536
[TBL] [Abstract][Full Text] [Related]
7. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.
Alric L; Plaisier E; Thébault S; Péron JM; Rostaing L; Pourrat J; Ronco P; Piette JC; Cacoub P
Am J Kidney Dis; 2004 Apr; 43(4):617-23. PubMed ID: 15042538
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of membranoproliferative glomerulonephritis associated with hepatitis B and C virus simultaneous infection patient.
Mima A; Iehara N; Matsubara T; Yamamoto S; Abe H; Nagai K; Matsuura M; Murakami T; Kishi S; Araoka T; Kishi F; Kondo N; Shigeta R; Yoshikawa K; Takahashi T; Kita T; Doi T; Fukatsu A
Clin Nephrol; 2010 Feb; 73(2):167-9. PubMed ID: 20129026
[No Abstract] [Full Text] [Related]
9. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection.
Johnson RJ; Gretch DR; Yamabe H; Hart J; Bacchi CE; Hartwell P; Couser WG; Corey L; Wener MH; Alpers CE
N Engl J Med; 1993 Feb; 328(7):465-70. PubMed ID: 7678440
[TBL] [Abstract][Full Text] [Related]
10. Progressive renal failure and blindness due to retinal hemorrhage after interferon therapy for hepatitis C virus-associated membranoproliferative glomerulonephritis.
Suzuki T; Yonemura K; Miyaji T; Suzuki H; Takahira R; Fujigaki Y; Fujimoto T; Hishida A
Intern Med; 2001 Aug; 40(8):708-12. PubMed ID: 11518107
[TBL] [Abstract][Full Text] [Related]
11. [Interferon therapy in cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection].
Mátyus J; Kovács J; Ujhelyi L; Kárpáti I; Dalmi L; Kakuk G
Orv Hetil; 1996 Nov; 137(45):2527-30. PubMed ID: 8999399
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon.
Chung DR; Yang WS; Kim SB; Yu E; Chung YH; Lee Y; Park JS
Am J Nephrol; 1997; 17(2):112-7. PubMed ID: 9096440
[TBL] [Abstract][Full Text] [Related]
13. [Virus associated glomerulonephritis].
Tillmann HL; Schwarz A
Internist (Berl); 2003 Sep; 44(9):1098-106. PubMed ID: 14566463
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hepatitis C-related kidney disease.
Fabrizi F; Martin P; Cacoub P; Messa P; Donato FM
Expert Opin Pharmacother; 2015; 16(12):1815-27. PubMed ID: 26161511
[TBL] [Abstract][Full Text] [Related]
15. Interferon toxicity in hepatitis C virus-associated type II cryoglobulinemia.
Di Lullo L; De Rosa FG; Coviello R; Sorgi ML; Coen G; Zorzin LR; Casato M
Clin Exp Rheumatol; 1998; 16(4):506. PubMed ID: 9706438
[No Abstract] [Full Text] [Related]
16. Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report.
Shimada M; Nakamura N; Endo T; Yamabe H; Nakamura M; Murakami R; Narita I; Tomita H
BMC Nephrol; 2017 Mar; 18(1):109. PubMed ID: 28356063
[TBL] [Abstract][Full Text] [Related]
17. Mixed cryoglobulinaemia and hepatitis C virus infection.
Grandinetti F; De Paola L; Prunesti P; Mazzitello G
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):579. PubMed ID: 9513839
[No Abstract] [Full Text] [Related]
18. Sofosbuvir and Daclatsvir in Treatment of Hepatitis C Virus-related Membranoproliferative Glomerulonephritis With Cryoglobulinemia in a Patient With Hepatitis C Genotype 4.
Elmowafy AY; El Maghrabi HM; Zahab MA; Elwasif SM; Bakr MA
Iran J Kidney Dis; 2018 Nov; 12(6):382-384. PubMed ID: 30595569
[TBL] [Abstract][Full Text] [Related]
19. Effect of antiviral therapy on hepatitis C virus related glomerulopathy.
Abbas G; Hussain S; Shafi T
Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):775-80. PubMed ID: 18711294
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis.
Garini G; Allegri L; Carnevali L; Catellani W; Manganelli P; Buzio C
Am J Kidney Dis; 2001 Dec; 38(6):E35. PubMed ID: 11728995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
